Form: EFFECT

Notice of Effectiveness

October 15, 2024

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: October 15, 2024
Accession Number: 0001140361-24-043036
Submission Type: POS AM
CIK: 0001444192
Company Name: Acasti Pharma Inc.
File Number: 333-280536